SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Ahlenius, S.
Right arrow Articles by Larsson, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ahlenius, S.
Right arrow Articles by Larsson, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effects of the putative 5-HT agonist 5-OH-DPAC on male rat sexual behaviour: a comparison with effects produced by 8-OH-DPAT and buspirone

Sven Ahlenius

Department of Neuropharmacology, Astra Research Centre, S-151 85 Södertälje, Sweden, Department of Psychology, Unit of Psychobiology, University of Göteborg, PO Box 14158, S-400 20 Göteborg, Sweden

Knut Larsson

Department of Psychology, Unit of Psychobiology, University of Göteborg, PO Box 14158, S-400 20 Göteborg, Sweden

The new 5-HT agonist 5-hydroxy-3-(di-n-propylamino)chroman (5-OH-DPAC), 0.025-3.2 mg:kg-1, produced a marked facilitation of male rat sexual behaviour, characterized by a decrease in the number of intromissions preceding ejaculation and in time to ejaculation. The compound is in this regard as efficacious as 8-OH-DPAT, but about 3 times less potent. Buspirone, 2-4 mg:kg-1, also produced a facilitation of the male rat sexual behaviour, but with less efficacy and with considerably less potency than either 8-OH-DPAT or 5-OH-DPAC. In the experiment where 5-OH-DPAC and 8-OH-DPAT were directly compared, the display of flat body posture was recorded immediately before the sexual behaviour observations. These observations indicate: (1) that the occurrence of this behavioural syndrome does not interfere with the performance of sexual behaviour in 8-OH-DPAT treated rats; and (2) at doses where the male rat sexual behaviour was affected to the same degree by 8-OH-DPAT and 5-OH- DPAC, only the former compound produced the flat body posture.

Journal of Psychopharmacology, Vol. 2, No. 1, 47-53 (1988)
DOI: 10.1177/026988118800200108


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement